Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission.

doi.org/10.3851/IMP2650, hdl.handle.net/1765/62927
Antiviral Therapy
,
Erasmus MC: University Medical Center Rotterdam

Pillay, D., Deenan, J., Bertagnolio, S., Boucher, C., Brun-Vézinet, F., Clotet, B., … Perno, C. (2013). Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network. Antiviral Therapy, 18(6), 831–836. doi:10.3851/IMP2650